Prof. Li Zhiming & Jing Hongmei: Otolizumab is very promising, and the new joint solution is expected to bring deeper relief to MCL
ARD: Targeting the IL-6-Yap-Snail signaling axis in synovial fibroblasts improves inflammatory arthritis
Lancet Oncol: Long-term (15 years) prognosis of early breast cancer with a single intraoperative radiotherapy
Cell Death Dis: A New Mechanism for Colorectal Cancer Metastay
Contact Us
Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
(We`ll never share your email address with a third-party.)
鲁ICP备16009155号-1 | Copyright@Qingdao ECHEMI Technology Co., Ltd.
Welcome to ECHEMI